Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive Fibrosing Interstitial Lung Disease”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Not applicableActive Not RecruitingNCT05492994
What this trial is testing

Test Different Imaging Techniques in Patients With Different Types of Interstitial Lung Disease

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 31
Testing effectiveness (Phase 2)Study completedNCT04308681
What this trial is testing

A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

Who this might be right for
Pulmonary Fibrosis
Bristol-Myers Squibb 403
Large-scale testing (Phase 3)Study completedNCT02999178
What this trial is testing

Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 663
Not applicableStudy completedNCT04702893
What this trial is testing

INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease (ILD) With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 108
Not applicableUnknownNCT05445817
What this trial is testing

Pulmonary Care and Research Collaborative Patient Registry

Who this might be right for
Interstitial Lung Disease
Pulmonary Care and Research Collaborative Limited 150
Not applicableUnknownNCT03858842
What this trial is testing

Non-interventional Study Describing Epidemiology, Prognosis and Patient Healthcare Costs in France, 2010-2017

Who this might be right for
Lung Diseases, InterstitialLung Disease With Systemic Sclerosis
Hospices Civils de Lyon 100
Not applicableStudy completedNCT04857814
What this trial is testing

Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases

Who this might be right for
Progressive Fibrosing Interstitial Lung DiseaseLung TransplantCystic Fibrosis+2 more
University of Alberta 8
Testing effectiveness (Phase 2)Looking for participantsNCT05139719
What this trial is testing

Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients

Who this might be right for
Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)
Sunshine Lake Pharma Co., Ltd. 110
Large-scale testing (Phase 3)WithdrawnNCT05067517
What this trial is testing

Efficacy & Safety of Nintedanib in Patients With Progressive Fibrosing Coal Mine Dust-Induced Interstitial Lung Disease

Who this might be right for
Progressive Fibrosing Interstitial Lung Disease
West Virginia University
Large-scale testing (Phase 3)Study completedNCT03820726
What this trial is testing

A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 435
Not applicableUnknownNCT05450276
What this trial is testing

Patient-Reported Outcome Study of Project ECHO for ILD

Who this might be right for
Interstitial Lung Disease
Pulmonary Care and Research Collaborative Limited 56
Not applicableActive Not RecruitingNCT05914506
What this trial is testing

Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease

Who this might be right for
Progressive Fibrosing Interstitial Lung Disease
University of Aarhus 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06422884
What this trial is testing

Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

Who this might be right for
Idiopathic Pulmonary FibrosisProgressive Fibrosing Interstitial Lung Disease
Endeavor Biomedicines, Inc. 213
Large-scale testing (Phase 3)Looking for participantsNCT06440746
What this trial is testing

Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseases

Who this might be right for
Lung Diseases, Interstitial
R-Pharm International, LLC 138
Large-scale testing (Phase 3)Study completedNCT05065190
What this trial is testing

Test How Well a Medicine Called Nintedanib Helps People in China With Progressive Lung Fibrosis

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 81
Large-scale testing (Phase 3)Study completedNCT05321082
What this trial is testing

Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 1,178
Not applicableStudy completedNCT04559581
What this trial is testing

Post-marketing Surveillance of Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype in Japan

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 425
Not applicableStudy completedNCT05875532
What this trial is testing

Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 34,960
Testing effectiveness (Phase 2)Looking for participantsNCT06329401
What this trial is testing

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisProgressive Pulmonary FibrosisPulmonary Fibrosis Secondary to Systemic Sclerosis+7 more
Avalyn Pharma Inc. 375
Not applicableNo Longer AvailableNCT04739150
What this trial is testing

An Expanded Access Program in Belgium to Provide Nintedanib to People With Lung Diseases Called Non-IPF ILDs Who Have no Alternative Treatment Options

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim
Load More Results